- Laboratory >
- Laboratory medicine >
- Rapid respiratory disease test >
- LumiraDx
LumiraDx rapid respiratory disease tests
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
Result display time: 12 min
... near-patient testing Minimal handling steps Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test ...
LumiraDx
Result display time: 5 min
... Instrument Minimal handling steps Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning ...
LumiraDx
Result display time: 11 min
Sensitivity: 84.6 % - 100 %
... infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care. Test benefits The LumiraDx SARS-CoV-2 Ab Test is designed to be ...
LumiraDx
Result display time: 5 min
... handling steps INQUIRE NOW Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning correctly ...
LumiraDx
Result display time: 12 min
... for pre entry or reopening of sites Test workflow The Instrument and Test Strips are integrated with several quality control checks to ensure the Instrument and Test are functioning ...
LumiraDx
Result display time: 12 min
... infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19. Test ...
LumiraDx
Your suggestions for improvement:
Receive monthly updates on this section.
Please refer to our Privacy Policy for details on how MedicalExpo processes your personal data.
- Brand list
- Manufacturer account
- Buyer account
- Our services
- Newsletter subscription
- About VirtualExpo Group
Please specify:
Help us improve:
remaining